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Abstract 
The highly conserved spindle assembly checkpoint (SAC) ensures that the sister 
chromatids of the duplicated genome are not separated and distributed to the 
spindle poles before all chromosomes have been properly linked to the microtubules 
of the mitotic spindle. Biochemically, the SAC delays cell cycle progression by 
preventing activation of the anaphase-promoting complex (APC/C) or cyclosome; 
whose activation by Cdc20 is required for sister-chromatid separation, which marks 
the transition into anaphase. In response to activation of the checkpoint, various 
species control the activity of both APC/C and Cdc20. However, the underlying 
regulatory pathways remain largely elusive.  
In this study, five possible model variants of APC/C regulation were constructed, 
namely BubR1, Mad2, MCC, MCF2 and an all-pathways model variant. These 
models are validated with experimental data from the literature. A wide range of 
parameter values have been tested to find critical values of the APC binding rate.  
The results show that all variants are able to capture the wild type behaviour of the 
APC. However, only one model variant, which included both MCC as well as BubR1 
as potent inhibitors of the APC, was able to reproduce both wild type and mutant 
type behaviour of APC regulation.     
The presented work has successfully distinguished between five competing 
dynamical models of the same biological system using a systems biology approach. 
Furthermore, the results suggest that systems-level approach is vital for molecular 
biology and could also be used for compare the pathways of relevance with the 
objective to generate hypotheses and improve our understanding. 
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Introduction  
Correct DNA segregation is a fundamental process that ensures the faithful inheritance of 
genomic information for the propagation of cell life. Eukaryotic cells have evolved a conserved 
surveillance control mechanism for DNA segregation called the Spindle Assembly Checkpoint 
(SAC;(Minshull, et al. 1994)). The SAC is responsible for delaying the onset of anaphase until 
all chromosomes have made amphitelic tight bipolar attachments to the mitotic spindle.   
The SAC works by inhibiting the anaphase-promoting complex (APC/C), presumably through 
sequestering the ACP/C-activator Cdc20. Upon APC/C activation, a signaling cascade is 
triggered that is not only responsible for degradation of mitotic cyclins, but additionally causes 
securin (budding yeast Pds1) to be tagged for degradation by the proteasome. Securin binds 
and thereby inhibits separase (budding yeast Esp1), a protease required to cleave cohesin, 
which is the ‘glue’ connecting the two sister-chromatids of every chromosome. Thus, activation 
of APC/C by Cdc20 initiates sister-chromatid separation, which marks the transition into 
anaphase (Musacchio and Salmon 2007). A dysfunction of the SAC can lead to aneuploidy 
(Suijkerbuijk and Kops 2008) and furthermore its reliable function is important for tumor 
suppression (Holland and Cleveland 2009,Morais da Silva, et al. 2013).   
The central proteins involved in SAC, that are  conserved in all eukaryotes,  include MAD 
(“Mitotic Arrest Deficient”; Mad1, Mad2, and Mad3 (in humans: BubR1))  (Li and Murray 1991) 
and BUB (“Budding Uninhibited by Benzimidazole”; Bub1, and Bub3) (Hoyt, et al. 1991). These 
proteins work to regulate APC/C activity and its co-activator Cdc20. In addition, the SAC also 
involves several other proteins that participate in important aspects of this mechanism. Among 
these additional proteins are Aurora-B (Vagnarelli and Earnshaw 2004) and the “Multipolar 
spindle-1” protein (Mps1) (Fisk, et al. 2004). These two components are required for SAC signal 
amplification. Moreover, several other components involved in carrying out essential aspects of 
the SAC mechanism have been identified in higher eukaryotes, for example, the RZZ complex 
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(Karess 2005,Lu, et al. 2009) which is composed of “Rough Deal” (Rod) (Raff, et al. 2002), 
Zeste White 10 (Saffery, et al. 2000a,Saffery, et al. 2000b) and Zwint-1(Kops, et al. 2005).  
The Cdc20-binding protein Mad2 was suggested as a candidate for the “wait-anaphase” signal, 
as it is stabilized in a conformation with increased affinity for Cdc20 specifically at unattached 
kinetochores.  The resulting Cdc20:C-Mad2 complex is diffusible and can bind to a complex of 
Bub3 and BubR1 to form the possibly transient mitotic checkpoint complex (MCC), which is a 
potent inhibitor of the APC. The MCC inhibits the APC/C in two ways. Firstly, it binds to the 
APC/C in a way preventing Cdc20 from interacting with mitotic APC-targets (Chao, et al. 2012). 
Secondly, it directs APC/C-activity towards ubiquitination of Cdc20 (Diaz-Martinez and Yu 
2007,Nilsson, et al. 2008). 
Cdc20:C-Mad2 can also directly bind to the APC/C and form an inactive complex (Fang, et al. 
1998).  It has been proposed that Mad2 may act as a catalyst for the assembly of a complex of 
Bub3:BubR1 with Cdc20 (Kulukian, et al. 2009a,Overlack, et al. 2014). Furthermore, BubR1 
was suggested to interact with APC/C (Han, et al. 2013). Another inhibitor, called the mitotic 
checkpoint factor 2 (MCF2), is associated with APC/C merely in the checkpoint arrested state 
but its composition is not known (Eytan, et al. 2008). With the exception of MCF2, all complexes 
inhibiting APC rely on the presence of Cdc20:C-Mad2, which requires unattached kinetochores 
for adequately fast formation. 
Computational models are important tools that help to elucidate how such elaborate systems 
may work (Ibrahim 2015). So far, mathematical models have helped to enlighten crucial 
modules of the SAC control mechanism, mainly the “Mad2 template”. Doncic et al. (Doncic, et 
al. 2005) likewise Sear and Howard (Sear and Howard 2006) examined simple spatial models of 
potential checkpoint mechanisms with focus on budding yeast or metazoan, respectively. They 
found that a diffusible signal can generally account for checkpoint operation. A more 
comprehensive model of the human SAC, including the Mad2 and BubR1 pathway has been 
proposed by Ibrahim et al. (Ibrahim, et al. 2008a,Ibrahim, et al. 2008b,Ibrahim and Henze 
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2014,Ibrahim, et al. 2009). A mathematical model for checkpoint activation based on the “Mad2 
template” model by De Antoni et al. (De Antoni, et al. 2005) is supported with in vitro 
experiments by Simonetta et al. (Simonetta, et al. 2009). Mistry et al. (Mistry, et al. 2008) 
constructed an elaborated model for the evolution over time of the kinetochore attachment 
states' distribution. Not only were the attached and unattached states considered, but also the 
merotelic and syntelic misalignments. Lohel et al. (Lohel, et al. 2009) accomplished a 
betterment of these models by taking into account species localization and binding sites at 
kinetochores.     
However, no modeling has been considered for the full SAC mechanism including all possible 
regulatory pathways of the APC. Here, five quantitative model variants for SAC activation and 
maintenance, considering all known pathways of APC/C regulation in human cells, will be 
discussed. All core proteins and their reactions are enabled with in-vitro measured 
concentrations and interaction rates. Thus, the simulations give a reliable insight into the 
behavior of the real SAC system. To mimic the majority of experimental findings, human as well 
as budding yeast cells are considered. Moreover, various mutations (deletion and 
overexpression) have been used to distinguish between these model variants.  
 
Materials and Methods 
Mathematical treatment and simulation 
By applying general principles of mass-action kinetics, the reaction rules were converted into 
sets of time dependent nonlinear ordinary differential equations (ODEs). The actual initial 
amounts for reaction species are taken from literature (cf. Table 1). When only a certain range 
was known, different starting values were used for the computations, but qualitatively differing 
trajectories were not found. The kinetic rate constants are also taken from literature as far as 
they are known. In the other cases, representative values exemplifying their whole 
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physiologically possible range were selected. A summary of all simulation parameters is given in 
Table 1.  
In a typical simulation run, all reaction partners were initialized according to Table 1 and 
numerically integrated the ODEs until steady state was reached before attachment (using u = 1, 
see chemical reaction scheme). After switching u to 0, the equations are again integrated, until 
steady state is reached. To solve the non-linear ODEs systems, a variety of computational 
approaches have been applied. In particular, high order (seven–eighth) Runge–Kutta (Fehlberg 
and Prince) formulas, a modified Rosenbrock formula, variable order Adams–Bashforth–
Moulton, backward differentiation formulas, and an implicit Runge–Kutta method. Switch 
between these methods are done automatically according to the system’s stiffness state. This 
helps to simulate wide range of parameters (e.g. 103-109) and also validate our solutions. The 
implementation and simulations code are written based on MATLAB (Mathworks, Natick, MA).  
 
Model assumptions  
Some reactions can depend on the attachment status of the kinetochores, so all reactions can 
be classified by whether they upon microtubule attachment are unaffected (“uncontrolled”), 
turned off (“off-controlled”) or turned on (“on-controlled”). Only reactions involving kinetochore 
localized species can be controlled. For example, formation of Mad1:C-Mad2:O-Mad2* 
(Reaction 2) can only take place as long as the kinetochores are unattached. In this model, if 
the kinetochore is unattached, u was set to u = 1, otherwise u = 0. Note that it is assumed that 
mass-action-kinetics is used for all reactions (Ibrahim, et al. 2008a,Ibrahim, et al. 2008b). If 
other kinetics should be used, they have to be transformed to mass action kinetics.  
Mad1:Mad2 is considered to be preformed complex and the complex formation is not 
considered. It should be noted that this complex is a tetrameric 2:2 Mad1:Mad2 and not a 
monomer complex. From mathematical point of view, considering the complex as a species 
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would not make any difference in this case as long as there is one form in our model. All 
previous mathematical models have considered the similar assumption to the template model 
(e.g.,(Ibrahim, et al. 2008a,Lohel, et al. 2009,Simonetta, et al. 2009)).  
 
Results and Discussion 
 
Biochemical background of the model 
The reaction network of the SAC activation and maintenance mechanism can be divided into 
kinetochore dependent and cytosolic (kinetochore independent) parts. The former serves to 
communicate the attachment status of each kinetochore to the remainder of the cell while the 
latter accounts for the actual inhibition of the APC.  
 
Template model of Mad2-activation 
The protein Mad2 is present in two stable conformations differing in the spatial arrangement of a 
‘safety-belt’ which is either open (O-Mad2) or closed (C-Mad2) (De Antoni, et al. 2005,Luo, et al. 
2004,Sironi, et al. 2002). O-Mad2 is able to bind Cdc20, though the resulting complex is rather 
transient. C-Mad2 cannot bind to Cdc20, but in contrast, the complex of C-Mad2 and Cdc20 is 
quite stable. Central to the SAC-network is a kinetochore-bound template complex made up 
from Mad1 and C-Mad2. This template complex recruits O-Mad2 and stabilizes an intermediate 
conformation (O-Mad2*) which can bind Cdc20 efficiently and switches to closed conformation 
upon Cdc20-binding, tightening the connection between both with the ‘safety-belt’ (De Antoni, et 
al. 2005,Luo, et al. 2004,Vink, et al. 2006). The C-Mad2:Cdc20 complex formed by this 
mechanism has been given the name “template-model” (De Antoni, et al. 2005).  
Mad2-activation at the kinetochores is commonly seen as the central element of the SAC. 
Therefore the template model of Mad2-activation is included into the model (De Antoni, et al. 
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2005,Ibrahim, et al. 2008b,Simonetta, et al. 2009). The kinetic rate coefficients for this 
interactions have been determined in vitro by Simonetta et al. (2009). The biochemical 
equations of the Mad2 Template Model are described by reaction (R1)–(R3) (see chemical 
reaction scheme, below).  
 
Autocatalytic amplification of Cdc20:C-Mad2 formation  
In addition to its activation via kinetochore-bound Mad1:C-Mad2, O-Mad2 can likewise be 
activated by Cdc20:C-Mad2 to autocatalytically increase Cdc20:C-Mad2 formation rate in vitro 
(Simonetta, et al. 2009). However, the contribution of this autocatalytic loop is minor with the 
kinetic data given in (Simonetta, et al. 2009). The presence of a highly contributing autocatalytic 
loop would also counteract checkpoint deactivation and is therefore not desirable for live cells 
from a theoretical point of view (Ibrahim, et al. 2008b). This loop is therefore not considered in 
the model.  For integrity, the biochemical equations of the autocatalytic amplification are listed 
by reaction (R4)–(R5) (see chemical reaction scheme, below). 
 
MCC formation 
Although Cdc20:C-Mad2 can bind to and inhibit APC directly, its inhibitory potency increases 
greatly in synergy with the Bub3:BubR1 complex (Musacchio and Salmon 2007). Cdc20:C-
Mad2 together with Bub3:BubR1 was shown to form the tetrameric mitotic checkpoint complex 
(MCC), which is a potent inhibitor of APC (Sudakin, et al. 2001). The trimeric complex 
Bub3:BubR1:Cdc20 is a potent inhibitor of APC, too (Malureanu, et al. 2009). However, the rate 
of its uncatalyzed formation in the cytosol is slow (Sudakin, et al. 2001). The formation of 
Bub3:BubR1:Cdc20 is accelerated in the presence of unattached chromosomes (Kulukian, et al. 
2009b) and it may be that MCC forms as an intermediate complex from which O-Mad2 rapidly 
dissociates (Kulukian, et al. 2009b,Malureanu, et al. 2009,Medema 2009). Microtubule 
attachment depletes the template-complexes from the respective kinetochore, thereby silencing 
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SAC-signaling locally (Buffin, et al. 2005,Sivaram, et al. 2009). Thus, after proper attachment of 
the last chromosome, SAC signaling ceases and passage to anaphase is granted. The MCC 
formation is described by the reaction (R6) (see chemical reaction scheme, below). 
 
APC inhibition 
The APC can be inhibited in multiple ways, and complexes of APC together with either 
Cdc20:C-Mad2, Bub3:BubR1, Bub3:BubR1:Cdc20, MCC or MCF2 have been found to be 
inactive (Eytan, et al. 2008,Herzog, et al. 2009,Kulukian, et al. 2009b,Malureanu, et al. 
2009,Medema 2009,Sudakin, et al. 2001). However, the demand mechanisms for binding the 
inhibitory complexes to the APC are subject to current research. 
The MCC may form more stably at unattached kinetochores and recruit APC from the cytoplasm  
(Herzog, et al. 2009). The MCC sub-complexes Bub3:BubR1:Cdc20 and Cdc20:C-Mad2 can 
bind to the APC independently from unattached kinetochores although their binding may be 
facilitated in a kinetochore-dependent manner (Kulukian, et al. 2009b,Malureanu, et al. 
2009,Medema 2009). The MCC may also bind to APC in a kinetochore independent manner to 
eventually inhibit APC by releasing O-Mad2, forming the stable Bub3:BubR1:Cdc20:APC 
complex. The recently discovered mitotic checkpoint factor 2 protein (MCF2) is a highly potent 
APC-inhibitor, yet the mechanism of binding to the APC and its regulation is still elusive 
(Braunstein, et al. 2007,Eytan, et al. 2008). All complexes inhibiting APC (except of MCF2) rely 
on the presence of Cdc20:C-Mad2, which requires unattached kinetochores for adequately fast 
formation.  The Cdc20:C-Mad2 complex can be characterized to be the “interface” connecting 
signaling from unattached kinetochores to APC inhibition. The APC regulation reactions are 
described by the reactions (R8)–(R10) (see chemical reaction scheme, below). 
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Chemical reaction scheme 
In this model of the SAC mechanism, 13 biochemical reaction equations describe the dynamics 
of the following 16 species: Mad1:C-Mad2, O-Mad2, Mad1:C-Mad2:O-Mad2*, Cdc20, Cdc20:C-
Mad2, Bub3:BubR1, MCC, Bub3:BubR1:Cdc20, APC, MCC:APC, APC:BubR1:Bub3, 
APC:Cdc20:C-Mad2, APC: Cdc20:BubR1:Bub3, MCF2, MCF2:APC, and APC:Cdc20. 
 
Cdc20 + O-Mad2 Cdc20:C-Mad2
k1
k-1
Mad1:C-Mad2 + O-Mad2 Mad1:C-Mad2:Mad2*
k2 . u
k-2
Mad1:C-Mad2:Mad2* + Cdc20 Mad1:C-Mad2 + Cdc20:C-Mad2
k3 . u
k-3
Cdc20:C-Mad2 + BubR1:Bub3 MCC
k6 . u
k-6
Cdc20 + BubR1:Bub3 Cdc20:BubR1:Bub3
k7
k-7
k-8
APC + Cdc20 APC:Cdc20
k9
k-9
APC + Cdc20:C-Mad2 APC:Cdc20:C-Mad2
k10 . u
k-10
MCF2 + APC MCF2:APC
k13 . u
k-13
APC + BubR1:Bub3 APC:BubR1:Bub3
k11 . u
k-11
Cdc20:C-Mad2 + O-Mad2 Mad1:C-Mad2:Mad2*
k4
k-4
Cdc20:C-Mad2:Mad2* + Cdc20 2Cdc20:C-Mad2
k5
k-5
MCC + APC MCC:APC
k8 . u
APC + Cdc20:BubR1:Bub3 APC:Cdc20:BubR1:Bub3
k12 . u
k-12
(R1)
(R2)
(R3)
(R6)
(R7)
(R9)
(R10)
(R13)
(R11)
(R4)
(R5)
(R8)
(R12)
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Dynamics of APC/C regulation   
Five model variants for the regulation of APC/C at meta- to anaphase transition have been 
constructed. As described in the literature, many proteins contribute to checkpoint function. The 
key players and their interactions are captured by the reaction equations introduced in the 
previous section. These equations are then transformed into ODEs and selected specific values 
for the initial concentrations and rate constants from the literature and our previous publications 
(summarized by Table 2). All model variants share the core template model of Mad2-activation 
(reactions (1)-(3)), MCC formation (Reactions (6)-(7)), MCC binding to APC (Reaction (8)), and 
APC activation by Cdc20 co-activator (Reaction 9) (see text above). They differ by the additional 
inhibitory pathway for the APC. Hence, the basic model has solely MCC as a direct binding 
partner and inhibitor to APC, namely the MCC dominated model variant (Reactions (1)-(9)). The 
second model variant consists of the basic MCC model as well as Mad2 as a direct inhibitor of 
APC, namely Mad2 dominated model variant (Reactions (1)-(10)). The third model variant the 
basic model and also BubR1 as direct inhibitor, the BubR1 dominated pathway. This pathway 
has two variants either binds APC (Reactions (1)-(9), and (11)) or BubR1:Cdc20 complex which 
is binds to APC (Reactions (1)-(9), and (12)). The fourth model contains MCF2 inhibition of APC 
in addition to MCC basic model (Reactions (1)-(9), and (13)). The fifth model variant includes all 
of the listed above variants simultaneously.  
In all simulations, APC:Cdc20 concentration is considered as comparison reference which 
should be close to zero before attachment and should rise quickly after attachment (spindle 
attachment occurs at t = 2000s). Reactions that are depending on kinetochore signal are 
switched from 1 to zero after attachment. All results are presented for different values of the rate 
k8 (MCC binding to APC). Parameters setting are according to Table 1.  Simulation shows that 
all other pathways in this study should be controlled same as MCC pathway. The type of control 
is unknown and kinetochore should be directly or indirectly involved. Thus, only the controlled 
pathway types will be shown in the simulation figure.   
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  MCC dominated model (MCC-APC pathway) 
The SAC model has been previously analyzed where MCC is the exclusive inhibitor of APC 
(Ibrahim, et al. 2008a).This model is used in this study as a core part (Reactions (1)-(9)) to build 
on and compare with other model variants. First, this basic model was re-simulated with various 
MCC-APC binding rates (103 to 109 M-1s-1). For all calculations, the concentrations and rates of 
Table 1 were chosen. In Figure 1, the APC:Cdc20 (active APC form) concentration is plotted for 
seven different values of k8 (MCC-APC binding rate). With increasing values of k8, a faster 
switching behavior is observed. The MCC shows sufficient inhibition of APC only when the 
binding rate is high enough (Fig. 1A). This could be the case; however, there is neither 
experimental data nor a theoretical indication showing the MCC-APC binding rate, yet.  
 
Mad2 dominated model (Mad2:Cdc20-APC pathway) 
In this model variant, in addition to the MCC model pathway (Reactions (R1)-(R9)), Mad2-
Cdc20 complex direct binding to APC (Reaction R10) is added. When simulating this model, 
considering the Reaction 10 binding rate the same as the MCC binding rate (Reaction 8), no 
changes were observed (same as Fig. 1A). As the Mad2 binding was increased gradually, it 
was discovered that the binding rate needed to be 1000 fold higher than MCC binding to APC in 
order to reach ideal inhibition (zero before attachment and max after attachment). These 
results are shown in Fig. 1B. 
 
BubR1 dominated model (BubR1- or BubR1:Cdc20-APC pathways) 
This model variant has two possibilities; the first variant is one where BubR1 directly binds the 
APC (Reaction R11) and second is where the BubR1:Cdc20 complex binds the APC (Reaction 
R12). The simulation of reaction (R1-R11) results in no effect as long as the binding rate is 
similar to MCC binding to APC. Once the rate increased 100 fold than the MCC-APC binding 
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rate, the inhibition of APC reached about zero level (Fig.1C). This value is exactly 10 fold less 
than the required rate for Mad2 binding to APC. This may imply that BubR1 is 10  fold more 
potent than Mad2 in inhibiting APC. Interestingly, this value is very similar to the experimental 
finding (Fang 2002) where they found that BubR1 is 12 fold more potent than Mad2. However, 
this could be incidental.  
The second variant where the BubR1:Cdc20 complex binds the APC, (R1-R10, and R12) shows 
no improvement for APC inhibition or recovery even with a very high binding rate (105 M-1s-1, 
Fig.1D, and compare to Fig.1A). This may imply that BubR1:Cdc20 is less likely to act as a 
direct inhibitor of APC while BubR1 alone does.  
 
MCF2 regulation model (MCF2-APC pathway) 
This variant considers MCF2 as a second direct binding partner to the APC in addition to the 
MCC (R13). The amount of MCF2 is still unknown and so the simulation was run twice; once 
when its amount is as half the amount of the APC and second where its amount is exactly as 
the APC amount.  Additionally, the binding rate is like the MCC-APC binding rate.  
The simulations are summarized in Fig. 1E and Fig. 1F. To achieve full inhibition of the APC, a 
high amount (same as APC amount which is 0.09 µM) as well as a high binding rate (105 M-1s-1) 
is required. 
All pathways simultaneously (MCC, Mad2, BubR1, and MCF2) 
There is still the possibility where all pathways regulate the APC simultaneously (Reaction R1-
R13). The simulation results of this model show ideal inhibition of the APC (very low before 
attachment and dramatically high after) with the condition that the binding rates are about 106.   
Taken together, to this end, any additional pathway can increase the inhibition of APC. All the 
variant models show the desired SAC mechanism. However, further analysis must be carried 
out to discriminate between these model variants.  
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Model validation by mutation experiments 
In order to validate all model variants and find out their limitation and constraints, different 
mutations (deletion and over-expression) of the proteins involved (Table 2) were tested. There 
are many experimental studies reported where deletion and also overexpression in different 
organisms of any of the core components, Mad2 (De Antoni, et al. 2005,Dobles, et al. 
2000,Fang, et al. 1998,He, et al. 1997,Kabeche and Compton 2012,Michel, et al. 2001,Nath, et 
al. 2012,Nezi, et al. 2006), BubR1 (Chan, et al. 1999,Davenport, et al. 2006,Harris, et al. 
2005,Ouyang, et al. 2002,Yamamoto, et al. 2007), and Cdc20 (Hwang, et al. 1998,Mondal, et al. 
2006,Mondal, et al. 2007,Shirayama, et al. 1999,Zhang and Lees 2001), resulted in SAC 
defects, such as  failed or successful mitotic arrest. These experiments helped in validating all 
model variants and additionally discriminating between them. The experiments from literature 
are listed in Table 2.    
In the simulations, the respective initial concentration was set to zero for the deletions, and 100 
fold higher concentrations for over-expression. The desired proper wild type functioning, 
APC:Cdc20 concentration should be very low (zero) before the attachment, and should increase 
quickly after attachment. Cells failing to arrest meant a very high level of APC:Cdc20 and low 
sequestration level of Cdc20. Arrested cells meant a very low level of APC:Cdc20 and full 
sequestration of Cdc20. The simulations show that all the above model variants are unable to 
fully reproduce all known experimental findings for the given parameter set (Table 2). Thus, the 
simulations were re-run with a larger range of parameter values and these results are 
summarized in Fig. 2. 
The MCC dominated model variant is shown in the first row of Fig. 2. Conjointly, deletion of 
Mad2 or BubR1 resulted in high APC:Cdc20 levels (0.09 µM) for any parameter set (103 -109 M-
1s-1) while overexpression of Cdc20 required that the APC binding rate must be less than 106 M-
1s-1.Overexpression of Mad2 or deleting Cdc20 resulted in low levels of APC:Cdc20 (very near 
to zero) for any parameter values while overexpression of BubR1 required that the APC binding 
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rate to be higher than 106 M-1s-1.  Taken together, for the MCC model variant, the APC-MCC 
binding rate must be exactly 106 M-1s-1. This rate is 10 fold less than the theoretical reported 
prediction (Ibrahim, et al. 2008a). With this rate, the wild type simulation cannot be met (low 
APC:Cdc20 before attachment and high after), see Fig. 1.A. Thus this model variant could be 
excluded.  
The simulation in the second row (Fig. 2) shows the BubR1 dominated variants (either BubR1-
APC or Cdc20:BubR1-APC). Both model variants acted rather similarly for BubR1, Cdc20 
deletion and Cdc20 or Mad2 overexpression. They differed in the deletion of Mad2 or 
overexpression of Cdc20. The BubR1-APC variant requires that the binding rate to be less than 
104 M-1s-1 whereas the Cdc20:BubR1-APC variant requires that the rate to be less than 106 M-1s-
1
.The later variant contradicted the requirements for the wild type simulation (see Fig. 1D). 
Therefore, Cdc20:BubR1-APC can be excluded.  
The Mad2 model variant is shown in the third row Fig. 2. There was no parameter set that can 
be used to reproduce all mutation experiments. For instance, BubR1 deletion needs a very low 
binding rate (104 M-1s-1) while overexpression of BubR1 requires high rate (higher than 104 M-1s-
1). Hence, Mad2 model variant is less likely to be a realistic pathway and may be excluded. 
The MCF2 variant (Fig. 2, fourth row) has no parameter value allowing it to reproduce the 
experimental results, so this model can be excluded. Also, a model where all variants are 
included was tested (last row, Fig. 2). This model indeed shows the fact that all pathways 
cannot work in parallel. For example, deletion of BubR1 requires  a binding rate of less than 104 
M-1s-1 while BubR1 overexpression requires binding rate of larger  than 104 M-1s-1. The wild type 
simulation for all model variants with low and high binding parameter values are shown in Figure 
3. Taken together, only the BubR1-APC model provided an ideal SAC functioning and was able 
to reproduce all experimental findings. This model has the MCC and BubR1 as a direct inhibitor 
of APC.  
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Conclusion 
The SAC is an intriguingly sensitive checkpoint. The SAC works by inhibiting the APC:Cdc20 
complex, which  triggers a signaling cascade resulting in sister-chromatid separation upon 
activation. The SAC delays mitotic progression even if only one kinetochore is not properly 
attached to the spindle (Musacchio and Salmon 2007). Though, it is still puzzling as to which 
molecular mechanisms can achieve reliable mitotic arrest while still remaining highly 
responsive. To complicate the matter even further, the SAC must link the biomechanics of the 
mitotic spindle with a biochemical signal transduction network, thus posing an inherently spatial 
problem.    
Quantitative analysis and computational modeling are very important tools to elucidate how 
such elaborate systems work (Ibrahim 2015). So far, mathematical models have helped to 
elucidate the kinetochore structure and with that the mitotic checkpoint mechanism (Doncic, et 
al. 2005,Görlich, et al. 2014,Ibrahim, et al. 2007,Ibrahim, et al. 2008b,Ibrahim and Henze 
2014,Ibrahim, et al. 2013,Kreyssig, et al. 2012,Kreyssig, et al. 2014,Lohel, et al. 2009,Sear and 
Howard 2006,Simonetta, et al. 2009,Tschernyschkow, et al. 2013). However, none of these 
models consider the APC regulatory pathways.  
Which component is able to bind and inhibit APC, is a crucial question for SAC regulation. It is a 
general problem of simulation studies to identify all reaction schemes and to incorporate them 
with all the correct reaction kinetics. In general, the method of analysis described here  can help 
to falsify false assumptions, but can hardly prove the correctness of a pathway (Popper 1935).   
In this analysis, it is found that the APC inhibition by only MCC or MCC in addition to MCF2 or 
Mad2 is very unlikely to describe SAC regulation. However, the direct inhibition of the APC by 
both BubR1 and MCC could be a basis for further pathway design.  The influence of Cdc20 
sequestration on SAC operation has been previously analyzed (Ibrahim, et al. 2008b,Musacchio 
and Salmon 2007). How far partial inhibition of the APC/C by the SAC is tolerable by mitotic 
control is currently unclear. As many of the basic reactions described here and previously 
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(Ibrahim, et al. 2008a) and for the experimentally determined values, do not lead to complete 
Cdc20 sequestration, the studies described here have suggested that the MCC directly binds 
and completely blocks the APC/C. APC/C activation can then be a consequence of a 
MCC:APC/C complex modification or rearrangement (Ibrahim, et al. 2008a). To investigate and 
decide on the further reaction scheme for direct inhibition of the APC, additional direct inhibitors 
were integrated into various models describing APC/C inhibition after metaphase to anaphase 
transition, this may serve as a basis for more complex investigations. An example in this context 
is the discovery of a pharmacologic, competitive inhibitor of both Cdc20 and Cdh1 tosyl-L-
arginine methyl ester (TAME, (Zeng, et al. 2010)). Also, a cell permeable pro-drug, pro-drug, 
proTAME, which causes a SAC-dependent mitotic arrest via perturbs the function of the APC/C 
(Zeng, et al. 2010). These data can be integrated in the presented MCC-BubR1 model. 
However, to make detailed analysis and perditions, more kinetic data is required such as 
binding rate for APC/C:Cdc20 in cells treated with proTAME/ or TAME, and other doses of the 
drug compared to the level of APC/C amount (c.f., 0.1µM - 1µM). Nevertheless, to have an idea, 
the TAME-model, APC:Cdc20 interaction is disrupted, was integrated into MCC-BubR1 model. 
The simulation results supported the view that this variant is SAC-dependent under the 
condition that TAME inhibition reduces at least one fold the APC:Cdc20 interaction rate (104 M-
1s-1). Under this condition, mutation experiments are also reproducible (data not shown).    
 
In order to accelerate the pace of molecular biology knowledge, rigorous theoretical analysis 
should be developed to link computational models of biological networks to experimental data in 
tight rounds of analysis and synthesis in an integrative systems biology framework (Ibrahim 
2015). It is anticipated that a systems biological approach of the SAC mechanism will serve as a 
basis to integrate future findings and evaluate novel hypotheses related to checkpoint 
architectures and regulation. 
 
17 
 
Acknowledgment  
I acknowledge Fouzia Ahmad for critically reading the manuscript. This work was 
supported by the European Commission HIERATIC Grant 062098/14. 
 
Author Disclosure Statement 
The author declares that no conflicting financial interests exist. 
 
References  
Braunstein I, Miniowitz S, Moshe Y, Hershko A.(2007). Inhibitory factors associated with 
anaphase-promoting complex/cylosome in mitotic checkpoint. Proc Natl Acad Sci U S A. 
104, 4870-5. 
Buffin E, Lefebvre C, Huang J, Gagou ME, Karess RE.(2005). Recruitment of Mad2 to the 
kinetochore requires the Rod/Zw10 complex. Curr Biol. 15, 856-61. 
Burton JL, Solomon MJ.(2007). Mad3p, a pseudosubstrate inhibitor of APCCdc20 in the spindle 
assembly checkpoint. Genes Dev. 21, 655-67. 
Chan GK, Jablonski SA, Sudakin V, Hittle JC, Yen TJ.(1999). Human BUBR1 is a mitotic 
checkpoint kinase that monitors CENP-E functions at kinetochores and binds the 
cyclosome/APC. J Cell Biol. 146, 941-54. 
Chao WC, Kulkarni K, Zhang Z, Kong EH, Barford D.(2012). Structure of the mitotic 
checkpoint complex. Nature. 484, 208-13. 
Davenport J, Harris LD, Goorha R.(2006). Spindle checkpoint function requires Mad2-
dependent Cdc20 binding to the Mad3 homology domain of BubR1. Exp Cell Res. 312, 
1831-42. 
De Antoni A, Pearson CG, Cimini D, Canman JC, Sala V, Nezi L, Mapelli M and others.(2005). 
The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly 
checkpoint. Curr Biol. 15, 214-25. 
Diaz-Martinez LA, Yu H.(2007). Running on a treadmill: dynamic inhibition of APC/C by the 
spindle checkpoint. Cell Div. 2, 23. 
Dobles M, Liberal V, Scott ML, Benezra R, Sorger PK.(2000). Chromosome missegregation and 
apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell. 101, 635-45. 
Doncic A, Ben-Jacob E, Barkai N.(2005). Evaluating putative mechanisms of the mitotic spindle 
checkpoint. Proc Natl Acad Sci U S A. 102, 6332-7. 
Eytan E, Braunstein I, Ganoth D, Teichner A, Hittle JC, Yen TJ, Hershko A.(2008). Two 
different mitotic checkpoint inhibitors of the anaphase-promoting complex/cyclosome 
antagonize the action of the activator Cdc20. Proc Natl Acad Sci U S A. 105, 9181-5. 
Fang G, Yu H, Kirschner MW.(1998). The checkpoint protein MAD2 and the mitotic regulator 
CDC20 form a ternary complex with the anaphase-promoting complex to control 
anaphase initiation. Genes Dev. 12, 1871-83. 
18 
 
Fang G.(2002). Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit anaphase-
promoting complex. Mol Biol Cell. 13, 755-66. 
Fisk HA, Mattison CP, Winey M.(2004). A field guide to the Mps1 family of protein kinases. 
Cell Cycle. 3, 439-42. 
Görlich D, Escuela G, Gruenert G, Dittrich P, Ibrahim B.(2014). Molecular Codes Through 
Complex Formation in a Model of the Human Inner Kinetochore. Biosemiotics. 7, 223-
247. 
Han JS, Holland AJ, Fachinetti D, Kulukian A, Cetin B, Cleveland DW.(2013). Catalytic 
assembly of the mitotic checkpoint inhibitor BubR1-Cdc20 by a Mad2-induced 
functional switch in Cdc20. Mol Cell. 51, 92-104. 
Harris L, Davenport J, Neale G, Goorha R.(2005). The mitotic checkpoint gene BubR1 has two 
distinct functions in mitosis. Exp Cell Res. 308, 85-100. 
He X, Patterson TE, Sazer S.(1997). The Schizosaccharomyces pombe spindle checkpoint 
protein mad2p blocks anaphase and genetically interacts with the anaphase-promoting 
complex. Proc Natl Acad Sci U S A. 94, 7965-70. 
Herzog F, Primorac I, Dube P, Lenart P, Sander B, Mechtler K, Stark H, Peters JM.(2009). 
Structure of the anaphase-promoting complex/cyclosome interacting with a mitotic 
checkpoint complex. Science. 323, 1477-81. 
Holland AJ, Cleveland DW.(2009). Boveri revisited: chromosomal instability, aneuploidy and 
tumorigenesis. Nat Rev Mol Cell Biol. 10, 478-87. 
Howell BJ, Hoffman DB, Fang G, Murray AW, Salmon ED.(2000). Visualization of Mad2 
dynamics at kinetochores, along spindle fibers, and at spindle poles in living cells. J Cell 
Biol. 150, 1233-50. 
Hoyt MA, Totis L, Roberts BT.(1991). S. cerevisiae genes required for cell cycle arrest in 
response to loss of microtubule function. Cell. 66, 507-17. 
Hwang LH, Lau LF, Smith DL, Mistrot CA, Hardwick KG, Hwang ES, Amon A, Murray 
AW.(1998). Budding yeast Cdc20: a target of the spindle checkpoint. Science. 279, 1041-
4. 
Ibrahim B, Dittrich P, Diekmann S, Schmitt E.(2007). Stochastic effects in a compartmental 
model for mitotic checkpoint regulation. Journal of Integrative Bioinformatics. 4,  
Ibrahim B, Diekmann S, Schmitt E, Dittrich P.(2008a). In-silico modeling of the mitotic spindle 
assembly checkpoint. PLoS One. 3, e1555. 
Ibrahim B, Dittrich P, Diekmann S, Schmitt E.(2008b). Mad2 binding is not sufficient for 
complete Cdc20 sequestering in mitotic transition control (an in silico study). Biophys 
Chem. 134, 93-100. 
Ibrahim B, Schmitt E, Dittrich P, Diekmann S.(2009). In silico study of kinetochore control, 
amplification, and inhibition effects in MCC assembly. Biosystems. 95, 35-50. 
Ibrahim B, Henze R, Gruenert G, Egbert M, Huwald J, Dittrich P.(2013). Spatial Rule-Based 
Modeling: A Method and Its Application to the Human Mitotic Kinetochore. Cells. 2, 
506-544. 
Ibrahim B, Henze R.(2014). Active Transport Can Greatly Enhance Cdc20:Mad2 Formation. 
International Journal of Molecular Sciences. 15, 19074-19091. 
Ibrahim B.(2015). Toward a systems-level view of mitotic checkpoints. Progress in Biophysics 
and Molecular Biology.  
Kabeche L, Compton DA.(2012). Checkpoint-independent stabilization of kinetochore-
microtubule attachments by Mad2 in human cells. Curr Biol. 22, 638-44. 
19 
 
Karess R.(2005). Rod-Zw10-Zwilch: a key player in the spindle checkpoint. Trends Cell Biol. 
15, 386-92. 
Kops GJ, Kim Y, Weaver BA, Mao Y, McLeod I, Yates JR, 3rd, Tagaya M, Cleveland 
DW.(2005). ZW10 links mitotic checkpoint signaling to the structural kinetochore. J Cell 
Biol. 169, 49-60. 
Kreyssig P, Escuela G, Reynaert B, Veloz T, Ibrahim B, Dittrich P.(2012). Cycles and the 
qualitative evolution of chemical systems. PLoS One. 7, e45772. 
Kreyssig P, Wozar C, Peter S, Veloz T, Ibrahim B, Dittrich P.(2014). Effects of small particle 
numbers on long-term behaviour in discrete biochemical systems. Bioinformatics. 30, 
i475-81. 
Kulukian A, Han JS, Cleveland DW.(2009a). Unattached kinetochores catalyze production of an 
anaphase inhibitor that requires a Mad2 template to prime Cdc20 for BubR1 binding. Dev 
Cell. 16, 105-17. 
Kulukian A, Han JS, Cleveland DW.(2009b). Unattached Kinetochores Catalyze Production of 
an Anaphase Inhibitor that Requires a Mad2 Template to Prime Cdc20 for BubR1 
Binding. Developmental Cell. 16, 105-117. 
Li R, Murray AW.(1991). Feedback control of mitosis in budding yeast. Cell. 66, 519-31. 
Lohel M, Ibrahim B, Diekmann S, Dittrich P.(2009). The role of localization in the operation of 
the mitotic spindle assembly checkpoint. Cell Cycle. 8, 2650-60. 
Lu Y, Wang Z, Ge L, Chen N, Liu H.(2009). The RZZ complex and the spindle assembly 
checkpoint. Cell Struct Funct. 34, 31-45. 
Luo X, Tang Z, Xia G, Wassmann K, Matsumoto T, Rizo J, Yu H.(2004). The Mad2 spindle 
checkpoint protein has two distinct natively folded states. Nat Struct Mol Biol. 11, 338-
45. 
Malureanu LA, Jeganathan KB, Hamada M, Wasilewski L, Davenport J, van Deursen 
JM.(2009). BubR1 N Terminus Acts as a Soluble Inhibitor of Cyclin B Degradation by 
APC/C-Cdc20 in Interphase. Developmental Cell. 16, 118-131. 
Medema RH.(2009). Relaying the Checkpoint Signal from Kinetochore to APC/C. 
Developmental Cell. 16, 6-8. 
Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M and 
others.(2001). MAD2 haplo-insufficiency causes premature anaphase and chromosome 
instability in mammalian cells. Nature. 409, 355-9. 
Minshull J, Sun H, Tonks NK, Murray AW.(1994). A MAP kinase-dependent spindle assembly 
checkpoint in Xenopus egg extracts. Cell. 79, 475-86. 
Mistry HB, MacCallum DE, Jackson RC, Chaplain MA, Davidson FA.(2008). Modeling the 
temporal evolution of the spindle assembly checkpoint and role of Aurora B kinase. Proc 
Natl Acad Sci U S A. 105, 20215-20. 
Mondal G, Baral RN, Roychoudhury S.(2006). A new Mad2-interacting domain of Cdc20 is 
critical for the function of Mad2-Cdc20 complex in the spindle assembly checkpoint. 
Biochem J. 396, 243-53. 
Mondal G, Sengupta S, Panda CK, Gollin SM, Saunders WS, Roychoudhury S.(2007). 
Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and 
aneuploidization in oral cancer. Carcinogenesis. 28, 81-92. 
Morais da Silva S, Moutinho-Santos T, Sunkel CE.(2013). A tumor suppressor role of the Bub3 
spindle checkpoint protein after apoptosis inhibition. J Cell Biol. 201, 385-93. 
20 
 
Musacchio A, Salmon ED.(2007). The spindle-assembly checkpoint in space and time. Nat Rev 
Mol Cell Biol. 8, 379-93. 
Nath S, Moghe M, Chowdhury A, Godbole K, Godbole G, Doiphode M, Roychoudhury 
S.(2012). Is germline transmission of MAD2 gene deletion associated with human fetal 
loss? Mol Hum Reprod. 18, 554-62. 
Nezi L, Rancati G, De Antoni A, Pasqualato S, Piatti S, Musacchio A.(2006). Accumulation of 
Mad2-Cdc20 complex during spindle checkpoint activation requires binding of open and 
closed conformers of Mad2 in Saccharomyces cerevisiae. J Cell Biol. 174, 39-51. 
Nilsson J, Yekezare M, Minshull J, Pines J.(2008). The APC/C maintains the spindle assembly 
checkpoint by targeting Cdc20 for destruction. Nat Cell Biol. 10, 1411-20. 
Ouyang B, Knauf JA, Ain K, Nacev B, Fagin JA.(2002). Mechanisms of aneuploidy in thyroid 
cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without 
mutations in BUB1 and BUBR1. Clin Endocrinol (Oxf). 56, 341-50. 
Overlack K, Krenn V, Musacchio A.(2014). When Mad met Bub. EMBO Rep. 15, 326-8. 
Popper KR. Logik der forschung: zur erkenntnistheorie der modernen naturwissenschaft. J. 
Springer; 1935. 
Raff JW, Jeffers K, Huang JY.(2002). The roles of Fzy/Cdc20 and Fzr/Cdh1 in regulating the 
destruction of cyclin B in space and time. J Cell Biol. 157, 1139-49. 
Saffery R, Irvine DV, Griffiths B, Kalitsis P, Choo KH.(2000a). Components of the human 
spindle checkpoint control mechanism localize specifically to the active centromere on 
dicentric chromosomes. Hum Genet. 107, 376-84. 
Saffery R, Irvine DV, Griffiths B, Kalitsis P, Wordeman L, Choo KH.(2000b). Human 
centromeres and neocentromeres show identical distribution patterns of >20 functionally 
important kinetochore-associated proteins. Hum Mol Genet. 9, 175-85. 
Sear RP, Howard M.(2006). Modeling dual pathways for the metazoan spindle assembly 
checkpoint. Proc Natl Acad Sci U S A. 103, 16758-63. 
Shirayama M, Toth A, Galova M, Nasmyth K.(1999). APC(Cdc20) promotes exit from mitosis 
by destroying the anaphase inhibitor Pds1 and cyclin Clb5. Nature. 402, 203-7. 
Simonetta M, Manzoni R, Mosca R, Mapelli M, Massimiliano L, Vink M, Novak B, Musacchio 
A, Ciliberto A.(2009). The influence of catalysis on mad2 activation dynamics. PLoS 
Biol. 7, e10. 
Sironi L, Mapelli M, Knapp S, De Antoni A, Jeang KT, Musacchio A.(2002). Crystal structure 
of the tetrameric Mad1-Mad2 core complex: implications of a 'safety belt' binding 
mechanism for the spindle checkpoint. EMBO J. 21, 2496-506. 
Sivaram MV, Wadzinski TL, Redick SD, Manna T, Doxsey SJ.(2009). Dynein light intermediate 
chain 1 is required for progress through the spindle assembly checkpoint. EMBO J. 28, 
902-14. 
Stegmeier F, Rape M, Draviam VM, Nalepa G, Sowa ME, Ang XL, McDonald ER, 3rd and 
others.(2007). Anaphase initiation is regulated by antagonistic ubiquitination and 
deubiquitination activities. Nature. 446, 876-81. 
Sudakin V, Chan GKT, Yen TJ.(2001). Checkpoint inhibition of the APC/C in HeLa cells is 
mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. Journal of Cell Biology. 
154, 925-936. 
Suijkerbuijk SJ, Kops GJ.(2008). Preventing aneuploidy: the contribution of mitotic checkpoint 
proteins. Biochim Biophys Acta. 1786, 24-31. 
21 
 
Tschernyschkow S, Herda S, Gruenert G, Doring V, Gorlich D, Hofmeister A, Hoischen C and 
others.(2013). Rule-based modeling and simulations of the inner kinetochore structure. 
Prog Biophys Mol Biol. 113, 33-45. 
Vagnarelli P, Earnshaw WC.(2004). Chromosomal passengers: the four-dimensional regulation 
of mitotic events. Chromosoma. 113, 211-22. 
Vink M, Simonetta M, Transidico P, Ferrari K, Mapelli M, De Antoni A, Massimiliano L and 
others.(2006). In vitro FRAP identifies the minimal requirements for Mad2 kinetochore 
dynamics. Curr Biol. 16, 755-66. 
Yamamoto Y, Matsuyama H, Chochi Y, Okuda M, Kawauchi S, Inoue R, Furuya T and 
others.(2007). Overexpression of BUBR1 is associated with chromosomal instability in 
bladder cancer. Cancer Genet Cytogenet. 174, 42-7. 
Zeng X, Sigoillot F, Gaur S, Choi S, Pfaff KL, Oh DC, Hathaway N and others.(2010). 
Pharmacologic inhibition of the anaphase-promoting complex induces a spindle 
checkpoint-dependent mitotic arrest in the absence of spindle damage. Cancer Cell. 18, 
382-95. 
Zhang Y, Lees E.(2001). Identification of an overlapping binding domain on Cdc20 for Mad2 
and anaphase-promoting complex: model for spindle checkpoint regulation. Mol Cell 
Biol. 21, 5190-9. 
 
    
   
 Figure 1: Dynamical behavior of APC:Cdc20 concentration versus time
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Figure 2: Simulation of Mad2, BubR1, and Cdc20 mutations for each model variant. 
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Figure 3: Simulation of APC:Cdc20 after model 
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Table 1: Model parameters  
 
Parameters 
 
Remarks 
Rate 
constants 
   
 
k1   1 x 103    M-1s-1 (Ibrahim, et al. 2008b,Musacchio and Salmon 2007) 
 
k2  2 x 105    M-1s-1 (Howell, et al. 2000,Vink, et al. 2006) 
 
k3  1 x 107    M-1s-1 (Ibrahim, et al. 2008b) 
 
k4  2 x 104    M-1s-1 (Ibrahim, et al. 2008b,Ibrahim and Henze 2014) 
 
k5  1 x 107    M-1s-1 (Ibrahim, et al. 2008b,Ibrahim and Henze 2014) 
 
k6  103-109    M-1s-
1
 
This study 
 
k7  1 x 104    M-1s-1 (Ibrahim, et al. 2008a,Ibrahim, et al. 2009) 
 
k8  1 x 108    M-1s-1 (Ibrahim, et al. 2008a) 
 
k9  5 x 106    M-1s-1 (Ibrahim, et al. 2008a) 
 
k10  103-109   M-1s-1 This study 
 
k11  103-109   M-1s-1 This study 
 
k12  103-109   M-1s-1 This study 
 
k13  103-109   M-1s-1 This study 
    
 
k
-1  1 x 10-2  s-1 (Ibrahim, et al. 2008b) 
 
k-2  2 x 10-1  s-1 (Howell, et al. 2000) 
 
k
-3          0   s-1 (Ibrahim, et al. 2008b) 
 
k-4  2 x 10-2  s-1 (Ibrahim, et al. 2008b,Ibrahim and Henze 2014) 
 
k
-5          0   s-1 (Ibrahim and Henze 2014) 
 
k
-6  1 x 10-2  s-1 (Ibrahim, et al. 2008a,Ibrahim, et al. 2009) 
 
k
-7  1 x 10-1  s-1 (Ibrahim, et al. 2008a,Ibrahim, et al. 2009) 
 
k
-8  8 x 10-2  s-1 (Ibrahim, et al. 2008a) 
 
k
-9 8 x 10-2  s-1 (Ibrahim, et al. 2008a) 
 
k
-10 1 x 10-2  s-1 This study 
 
k
-11 1 x 10-2  s-1 This study 
 
k
-12 1 x 10-2  s-1 This study 
 
k
-13 1 x 10-2  s-1 This study 
Initial 
amount 
   
 
Cdc20   0.22  µM    (Fang 2002,Stegmeier, et al. 2007) 
 
O-Mad2  0.15  µM    (Howell, et al. 2000,Ibrahim, et al. 2008a,Lohel, et al. 2009) 
 
Mad1:C-Mad2  0.05  µM (De Antoni, et al. 2005,Ibrahim, et al. 2008a,Lohel, et al. 2009) 
 
BubR1:Bub3  0.13  µM (Burton and Solomon 2007,Fang 2002,Ibrahim, et al. 2008a) 
 
APC  0.09  µM (Stegmeier, et al. 2007) 
 
MCF2 
  
(Eytan, et al. 2008) , this study  
 
Other species start from zero 
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Table 2: In-silico mutation experiments for validation  
Species 
E
xp
.
 
Experimental effects 
Effects in the model variants 
MCC BubR1 BubR1:Cdc20 Mad2:Cdc20 MCF2 All pathways 
Mad2 D Cells are unable to arrest and impaired 
SAC (e.g., (Dobles, et al. 2000,Fang, et 
al. 1998,Michel, et al. 2001,Nath, et al. 
2012,Nezi, et al. 2006)) 
Failed to 
arrest 
Failed to arrest  
k11        <10-4 *k8  
k8, k11<105M-1s-
1
 
Failed to arrest  
k12        < 10-2 *k8  
k8, k11<107M-1s-1 
Failed to arrest Failed to arrest  
k13         < 10-4 *k8  
k8,k13<105 M-1s-1 
Failed to arrest   
all pathways  
< 105 M-1s-1 
Mad2 O Activates the SAC and blocks mitosis 
and stabilizes microtubule attachment 
((De Antoni, et al. 2005,He, et al. 
1997,Kabeche and Compton 2012))  
Arrested Arrested Arrested Arrested Arrested Arrested 
BubR1 D SAC dysfunction (Chan, et al. 
1999,Davenport, et al. 2006,Harris, et 
al. 2005,Ouyang, et al. 2002) 
Failed to 
arrest 
Failed to arrest Failed to arrest Failed to arrest  
k11        < 10-4 *k8  
k8, k10<105M-1s-1 
Failed to arrest  
k11         < 10-4 *k8  
k8, k13<105M-1s-1 
Failed to arrest   
All pathways  
< 105  M-1s-1 
BubR1 O Chromosomal instability (Yamamoto, et 
al. 2007) 
Arrested Arrested Arrested Arrested Arrested Arrested 
Cdc20 D 
Cells arrested in metaphase (Mondal, 
et al. 2006,Shirayama, et al. 
1999,Zhang and Lees 2001) 
Arrested Arrested Arrested Arrested Arrested Arrested 
Cdc20 O Impairment SAC and allows cells with a 
depolymerized spindle or damaged 
DNA to leave mitosis (Hwang, et al. 
1998,Mondal, et al. 2007). 
Failed to 
arrest  
k8 < 105 
Failed to arrest  
k8, k11<106M-1s-
1
 
Failed to arrest  
k8, k12<106 M-1s-1 
Failed to arrest  
k8, k10<106 M-1s-1 
Failed to arrest  
k8,k13<106M-1s-1 
Failed to arrest  
 
D refers to deletion or knockdown experiment, and O refers to an over-expression experiment.  
Failed to arrest means very high level of APC:Cdc20 and low sequestration level of Cdc20. Arrested means very low level of APC:Cdc20 and fully sequestration 
of Cdc20.  
